How much is the Botanical and Plant-Derived Drugs Market market?

The botanical and plant-derived drugs market market size is estimated to grow at $$ 20.93 bn in 2023. Read More

What is the growth rate of the Botanical and Plant-Derived Drugs Market market?

The growth rate of the botanical and plant-derived drugs market year-over-year is 8.18%. Read More

Which region held the largest market share in the Botanical and Plant-Derived Drugs Market market?

Asia is the region to held the largest market share with 44% growth. Read More

Who are the key players in the Botanical and Plant-Derived Drugs Market market?

Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche .... Read More

Which Segment has the largest market share in the Botanical and Plant-Derived Drugs Market market?

Type is the segment that has the largest market share in the market. Read More

Botanical and Plant-Derived Drugs Market Analysis Asia, Europe, North America, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Feb 2024
Pages: 177
SKU: IRTNTR45751

Enjoy complimentary customisation on priority with our Enterprise License!

Botanical and Plant-Derived Drugs Market Size 2024-2028

The global botanical and plant-derived drugs market size is estimated to grow by USD 20.93 billion, at a CAGR of 8.18% between 2023 and 2028. Besides analyzing the current market scenario. Government initiatives worldwide are driving the development of plant-based drugs, with global healthcare systems increasingly embracing herbal medicines. In countries like China, India, Nigeria, and the US, as well as organizations like WHO, significant R&D investments are being made. Governments incentivize industry players to invest in plant-based drug R&D through contracts and grants. For instance, PlantForm, under a Government of Canada contract, is developing a plant-based antibody for ricin exposure. Similarly, the College of Pharmacy in Chicago is researching botanical dietary supplements' safety and efficacy for women's health with NIH grants. Hence such factors will have a positive impact on the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Type, Application, and Geography Analysis

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global botanical and plant-derived drugs market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global botanical and plant-derived drugs market 2018 - 2022 ($ billion)

4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)

4.3 Application Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Oral - Market size and forecast 2023-2028
- Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)

6.4 Injectables - Market size and forecast 2023-2028
- Exhibit 38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)

6.5 Topicals - Market size and forecast 2023-2028
- Exhibit 42: Chart on Topicals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Topicals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Topicals - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Topicals - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Type
- Exhibit 46: Market opportunity by Type ($ billion)
- Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Application

7.1 Market segments
- Exhibit 48: Chart on Application - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Application - Market share 2023-2028 (%)

7.2 Comparison by Application
- Exhibit 50: Chart on Comparison by Application
- Exhibit 51: Data Table on Comparison by Application

7.3 Infectious diseases - Market size and forecast 2023-2028
- Exhibit 52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)

7.4 Central nervous system - Market size and forecast 2023-2028
- Exhibit 56: Chart on Central nervous system - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Central nervous system - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Central nervous system - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Central nervous system - Year-over-year growth 2023-2028 (%)

7.5 Cardiovascular diseases - Market size and forecast 2023-2028
- Exhibit 60: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)

7.6 Respiratory diseases - Market size and forecast 2023-2028
- Exhibit 64: Chart on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Respiratory diseases - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Respiratory diseases - Year-over-year growth 2023-2028 (%)

7.7 Digestive diseases and others - Market size and forecast 2023-2028
- Exhibit 68: Chart on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Data Table on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 70: Chart on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
- Exhibit 71: Data Table on Digestive diseases and others - Year-over-year growth 2023-2028 (%)

7.8 Market opportunity by Application
- Exhibit 72: Market opportunity by Application ($ billion)
- Exhibit 73: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 75: Chart on Market share by geography 2023-2028 (%)
- Exhibit 76: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 77: Chart on Geographic comparison
- Exhibit 78: Data Table on Geographic comparison

9.3 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 North America - Market size and forecast 2023-2028
- Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 Japan - Market size and forecast 2023-2028
- Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 115: Market opportunity by geography ($ billion)
- Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 117: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 118: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 119: Overview on factors of disruption

11.4 Industry risks
- Exhibit 120: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 121: Vendors covered

12.2 Market positioning of vendors
- Exhibit 122: Matrix on vendor position and classification

12.3 Bausch Health Companies Inc.
- Exhibit 123: Bausch Health Companies Inc. - Overview
- Exhibit 124: Bausch Health Companies Inc. - Business segments
- Exhibit 125: Bausch Health Companies Inc. - Key news
- Exhibit 126: Bausch Health Companies Inc. - Key offerings
- Exhibit 127: Bausch Health Companies Inc. - Segment focus

12.4 Bayer AG
- Exhibit 128: Bayer AG - Overview
- Exhibit 129: Bayer AG - Business segments
- Exhibit 130: Bayer AG - Key news
- Exhibit 131: Bayer AG - Key offerings
- Exhibit 132: Bayer AG - Segment focus

12.5 Boehringer Ingelheim International GmbH
- Exhibit 133: Boehringer Ingelheim International GmbH - Overview
- Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 135: Boehringer Ingelheim International GmbH - Key news
- Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus

12.6 Devonian Health Group Inc.
- Exhibit 138: Devonian Health Group Inc. - Overview
- Exhibit 139: Devonian Health Group Inc. - Product / Service
- Exhibit 140: Devonian Health Group Inc. - Key offerings

12.7 Dr. Willmar Schwabe GmbH and Co. KG
- Exhibit 141: Dr. Willmar Schwabe GmbH and Co. KG - Overview
- Exhibit 142: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
- Exhibit 143: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings

12.8 F. Hoffmann La Roche Ltd.
- Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus

12.9 Jaguar Health Inc.
- Exhibit 149: Jaguar Health Inc. - Overview
- Exhibit 150: Jaguar Health Inc. - Business segments
- Exhibit 151: Jaguar Health Inc. - Key offerings
- Exhibit 152: Jaguar Health Inc. - Segment focus

12.10 Jazz Pharmaceuticals Plc
- Exhibit 153: Jazz Pharmaceuticals Plc - Overview
- Exhibit 154: Jazz Pharmaceuticals Plc - Product / Service
- Exhibit 155: Jazz Pharmaceuticals Plc - Key news
- Exhibit 156: Jazz Pharmaceuticals Plc - Key offerings

12.11 Merck KGaA
- Exhibit 157: Merck KGaA - Overview
- Exhibit 158: Merck KGaA - Business segments
- Exhibit 159: Merck KGaA - Key news
- Exhibit 160: Merck KGaA - Key offerings
- Exhibit 161: Merck KGaA - Segment focus

12.12 Novartis AG
- Exhibit 162: Novartis AG - Overview
- Exhibit 163: Novartis AG - Business segments
- Exhibit 164: Novartis AG - Key offerings
- Exhibit 165: Novartis AG - Segment focus

12.13 Pfizer Inc.
- Exhibit 166: Pfizer Inc. - Overview
- Exhibit 167: Pfizer Inc. - Product / Service
- Exhibit 168: Pfizer Inc. - Key news
- Exhibit 169: Pfizer Inc. - Key offerings

12.14 Pierre Fabre SA
- Exhibit 170: Pierre Fabre SA - Overview
- Exhibit 171: Pierre Fabre SA - Business segments
- Exhibit 172: Pierre Fabre SA - Key offerings
- Exhibit 173: Pierre Fabre SA - Segment focus

12.15 Protalix Biotherapeutics Inc.
- Exhibit 174: Protalix Biotherapeutics Inc. - Overview
- Exhibit 175: Protalix Biotherapeutics Inc. - Product / Service
- Exhibit 176: Protalix Biotherapeutics Inc. - Key offerings

12.16 Sanofi SA
- Exhibit 177: Sanofi SA - Overview
- Exhibit 178: Sanofi SA - Business segments
- Exhibit 179: Sanofi SA - Key news
- Exhibit 180: Sanofi SA - Key offerings
- Exhibit 181: Sanofi SA - Segment focus

12.17 Sun Pharmaceutical Industries Ltd.
- Exhibit 182: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 183: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 184: Sun Pharmaceutical Industries Ltd. - Key news
- Exhibit 185: Sun Pharmaceutical Industries Ltd. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 186: Inclusions checklist
- Exhibit 187: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 188: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 189: Research methodology
- Exhibit 190: Validation techniques employed for market sizing
- Exhibit 191: Information sources